Browsing Tag
GV
8 posts
Eli Lilly targets autoimmune pipeline with $2.875bn Merida Biosciences acquisition
Eli Lilly is paying up to $2.875 billion for privately held Merida Biosciences only about 17 months after the biotech launched with $121 million. The lead asset remains in Phase 1, making the transaction less a conventional pipeline purchase than a bet that selectively eliminating disease-causing antibodies can open a new class of autoimmune and allergy medicines.
Obsidian Security becomes unicorn as enterprises seek controls for autonomous AI agents
Palo Alto-based Obsidian Security has secured an $85 million Series D led by Crescent Cove Advisors, turning the enterprise cybersecurity company into a unicorn. The financing gives Obsidian more runway to expand AI-agent governance, but its $1.1 billion valuation will ultimately depend on whether runtime controls can become a repeatable enterprise security standard.
Can Harbor Health’s Rippl deal redefine dementia care economics in Texas and beyond?
Harbor Health acquires Rippl to expand dementia care and strengthen its pay-vider model. Discover what this means for Texas healthcare markets.
Why Ramp’s $22.5bn valuation has investors chasing the future of AI‑driven expense management
Ramp raises $500M at a $22.5B valuation to scale autonomous AI agents for finance. Find out how Ramp Business Corporation is changing workflows today.
Chronosphere raises additional $115m for cloud observability platform
Chronosphere, a US-based cloud observability platform provider, has secured an additional $115 million Series C funding, to take…
Vertical farming company Bowery Farming raises $300m in new funding round
Bowery Farming, a US vertical farming company, has raised $300 million in its latest funding round to take…
Life insurance startup Ethos secures $60m in Series C financing
Ethos, a US-based life insurance fintech startup, has secured a $60 million investment in a Series C financing,…
Evox Therapeutics secures ÂŁ35.5m in Series B to advance exosome therapeutics
Evox Therapeutics, an innovative biotechnology company spun out from Oxford University, has successfully raised ÂŁ35.5 million in a…